Delivery Order SPE2DB20D2014-SPE2DB25FC23P
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,593.77 on August 1, 2025, for the supply of Calquence 100 mg tablets (60 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 22, 2025, and performance to be fulfilled at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's broader relationship with DLA, leveraging the company's...
- The Defense Logistics Agency awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp for Calquence 100 mg tablets (60-count units) on August 20, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp for Calquence 100 mg tablets (60-count units) on August 19, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a ceiling value of $5,593.77. This firm fixed-price delivery order is set to be completed by June 23, 2025, and represents performance from AmerisourceBergen's Conshohocken, Pennsylvania location. The award is issued under a competitive, non-set-aside procurement mechanism, reflecting AmerisourceBergen's established capability as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Calquence 100 mg tablets (60-count package) valued at $11,187.56. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 2, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement under the company's existing indefinite...
- The Defense Logistics Agency awarded a $5,593.77 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Calquence 100 mg tablets (60-count packages). This contract utilizes a firm fixed price model with an ultimate completion date of August 12, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a ceiling value of $11,187.56. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a competitive award with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $5,593.77 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Calquence 100 mg tablets (60-count units) with an ultimate completion date of August 8, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is a child contract executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $5,593.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Calquence 100 mg tablets (60-count units). The contract, which is expected to be completed by August 11, 2025, is non-set-aside and represents a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Calquence 100 mg tablets (60-count units) under a firm fixed price arrangement. The contract ceiling value is $11,187.56, with an ultimate completion date of September 24, 2025. This is an unset-aside, competitively awarded delivery order executed as a child contract under AmerisourceBergen's larger pharmaceutical supply framework. The performance location is...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC23PDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $27,969 to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60-count units) with a completion date of July 10, 2025. This firm fixed-price contract, awarded June 17, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, supporting federal medical supply requirements for the Department of Defense and related military healthcare systems. This delivery order is issued as a child contract under AmerisourceBergen's $999.999 billion Indefinite Delivery/Indefinite Quantity (IDIQ) prime vendor contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026. The IDIQ serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad spectrum of pharmaceutical products, generic and brand-name medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contracting history demonstrates its capability to manage complex medical procurement requirements across multiple therapeutic domains through competitive award mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.0k | 6/17/25 |